Substance P-Mediated Cardiovascular Inflammation
Substance P-Mediated Cardiovascular Inflammation
批准号:
6844695
负责人:
William Bernard Weglicki
金额:
$30.4万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-02-01 至 2008-01-31
关键词:
NMDA receptorsantiinflammatory agentscardiovascular systemdietary mineralgastrointestinal functiongastrointestinal systemgene expressionheart contractioninflammationintestinal mucosalaboratory mouselaboratory ratmagnesium deficiencymyocardial ischemia /hypoxiamyocardium disorderneprilysinneuroimmunomodulationneuropeptide receptorneurotoxicologyneurotransmitter biosynthesisneurotransmitter transportnutrient requirementnutrition related tagoxidative stresspathologysepticemiasubstance P
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposal addresses the pathobiology of inflammation of the heart due to neurogenic peptides, particularly substance P (SP). Recent data have provided support for the neuronal NMDA receptor contribution to the cardiovascular inflammatory process due to Mg-deficiency (MgD). In addition concurrent intestinal inflammation may enhance the later phase of the cardiomyopathy via activation of PMNs and endotoxin signaling. These recent findings provide the basis for the following Aims and collaborations: Aim 1. Assess the contribution of NMDA-receptor activation to the early SP elevation and how SP can be modulated during the acute "trigger phase" of dietary MgD. Aim 2. Determine the extent of NK-1 receptor expression and proinflammatory/oxidative response in the circulation and cardiac tissues during MgD. Aim 3. (with Dr. Shea-Donohue) Assess if MgD induces a neurogenic inflammation in the gut that is associated with altered intestinal function, enhanced mucosa barrier permeability, and increased sensitivity to oxidative stress; assess if systemic inflammatory response syndrome (SIRS) or endotoxemia contribute significantly to "cardiac inflammation/cardiomyopathy at a distance." Aim 4. Assess whether defects in baseline contractility of perfused rat heads develops during the late response phase of MgD and if in vivo interventions (MK-801, NK-1 receptor blocker, RTX, phosphoramidon, antibiotics) have a significant impact on cardiac baseline contractility dysfunction and tolerance to ltR stress. Aim 5. Assess if proinflammatory effects of MgD are altered in LPS-resistant vs. sensitive mice. We will employ a combination of immunohistochemical and molecular/protein biology (RT-PCR, Western-blotting) techniques, and gene chip technology to assess relevant genetic expression; more traditional biochemical (tissue glutathione and antioxidant status, plasma isoprotane level) and biophysical (ESR-spin trapping of free radicals and NO in isolated perfused heads) approaches will also be used.The hypotheses to be pursued in the Research Plan are outlined in Illustration 1. The potential relevance of clinical MgD to proinflammatory events in heart failure and other disease processes is addressed in the text.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EGFR Tyrosine Kinase Inhibition - Induced Cardiomyopathy
-
批准号:8399041
-
项目类别:
-
资助金额:$15.09万
-
财政年份:2011
-
负责人:William Bernard Weglicki
-
依托单位:
EGFR Tyrosine Kinase Inhibition - Induced Cardiomyopathy
-
批准号:8243940
-
项目类别:
-
资助金额:$27.74万
-
财政年份:2011
-
负责人:William Bernard Weglicki
-
依托单位:
CARDIOMYOPATHY:PRO-OXIDANT ROLE OF AZT & MG-DEFICIENCY
-
批准号:6149273
-
项目类别:
-
资助金额:$34.24万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
OXIDATIVE STRESS AND ANTIOXIDANTS IN IRON OVERLOAD
-
批准号:6090836
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
CARDIOMYOPATHY:PRO-OXIDANT ROLE OF AZT & MG-DEFICIENCY
-
批准号:6537840
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
OXIDATIVE STRESS AND ANTIOXIDANTS IN IRON OVERLOAD
-
批准号:6750773
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
Oxidative Stress And Antioxidants in Iron Overload
-
批准号:7421044
-
项目类别:
-
资助金额:$38.58万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
Oxidative Stress And Antioxidants in Iron Overload
-
批准号:7825432
-
项目类别:
-
资助金额:$38.58万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
Oxidative Stress And Antioxidants in Iron Overload
-
批准号:7259758
-
项目类别:
-
资助金额:$39.9万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
CARDIOMYOPATHY:PRO-OXIDANT ROLE OF AZT & MG-DEFICIENCY
-
批准号:6638667
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
SUBSTANCE P-MEDIATED CARDIOVASCULAR INFLAMMATION
-
批准号:6629015
-
项目类别:
-
资助金额:$31.99万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
OXIDATIVE STRESS AND ANTIOXIDANTS IN IRON OVERLOAD
-
批准号:6390951
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
SUBSTANCE P-MEDIATED CARDIOVASCULAR INFLAMMATION
-
批准号:6345816
-
项目类别:
-
资助金额:$3.85万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
SUBSTANCE P-MEDIATED CARDIOVASCULAR INFLAMMATION
-
批准号:6040838
-
项目类别:
-
资助金额:$29.37万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
OXIDATIVE STRESS AND ANTIOXIDANTS IN IRON OVERLOAD
-
批准号:6537931
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
Cardiomyopathy:Pro-Oxidant Role of Zidovudine (AZT)
-
批准号:7061279
-
项目类别:
-
资助金额:$33.62万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
Substance P-Mediated Cardiovascular Inflammation
-
批准号:6680138
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
Cardiomyopathy: Pro-Oxidant Role of Zidovudine (AZT)
-
批准号:7229466
-
项目类别:
-
资助金额:$32.64万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
Cardiomyopathy:Pro-Oxidant Role of Zidovudine (AZT)
-
批准号:6937241
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
Substance P-Mediated Cardiovascular Inflammation
-
批准号:7174228
-
项目类别:
-
资助金额:$28.82万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
海外基金